Skip to content

Assembly Biosciences ASMB Debt Securities Realized Gain Loss

Debt Securities Realized Gain Loss at other companies

Bridgewater Bancshares, Inc. logo
Bridgewater Bancshares, Inc.BWB
$7.25M+725,000%
Amalgamated Financial Corp. logo
Amalgamated Financial Corp.AMAL
-$822K-20.9%
USCB Financial Holdings, Inc. logo
USCB Financial Holdings, Inc.USCB
$14K
Chemung Financial logo
Chemung FinancialCHMG
-$4.37M
Bank7 Corp. logo
Bank7 Corp.BSVN
$0
Acacia Research logo
Acacia ResearchACTG
-$605K-138%

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesRealizedGainLoss.

The official record: Assembly Biosciences’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's debt securities realized gain loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's debt securities realized gain loss?
Assembly Biosciences (ASMB) reported debt securities realized gain loss of $750 in Q4 2025.
What does debt securities realized gain loss mean?
This reflects the net gain or loss recognized upon the sale or maturity of debt securities held in the company's investment portfolio. It adjusts net income to reconcile with cash flow, as these gains or losses are non-operating in nature. Tracking this provides insight into the performance of the company's treasury management and investment strategy.